News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
92 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25774)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (208)
2 (92)
4 (7)
5 (167)
6 (192)
7 (172)
8 (177)
9 (73)
10 (39)
11 (36)
12 (204)
13 (174)
14 (134)
15 (167)
16 (74)
18 (3)
19 (175)
20 (146)
21 (138)
22 (109)
23 (39)
24 (2)
25 (3)
26 (3)
27 (42)
28 (46)
29 (40)
30 (19)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
GSK intends to file for approval of Jemperli in endometrial cancer after the checkpoint inhibitor met its primary endpoint in the Phase III RUBY trial.
December 2, 2022
·
2 min read
·
Alex Keown
Drug Development
FDA Greenlights Rigel’s Rezlidhia in IDH1-Mutation AML
The FDA has approved Rigel’s Rezlidhia for the treatment of adults with relapsed or refractory AML with a susceptible isocitrate dehydrogenase-1 mutation.
December 2, 2022
·
2 min read
·
Mark Terry
Drug Development
CTAD: TauRx Touts Safety Profile as Anavex Stumbles over Data Discrepency (Updated)
TauRx Pharmaceuticals and Anavex Life Sciences presented positive results from their candidates at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Francisco, CA.
December 2, 2022
·
3 min read
·
Kate Goodwin
Drug Development
Amid Buyout Buzz, Mirati Pushes Phase III NSCLC Study to Final Analysis
Amid rampant buyout speculation, Mirati Therapeutics reported that it will continue its final analysis of the Phase III SAPPHIRE trial following an interim survival analysis.
December 2, 2022
·
2 min read
·
Alex Keown
Deals
FUJIFILM Diosynth Biotechnologies: There’s a New Cell Therapy Employer in Thousand Oaks
FUJIFILM Diosynth Biotechnologies is offering unique opportunities to join one of the top global CDMOs focused on solving some of the most complex healthcare challenges.
December 2, 2022
·
5 min read
·
Heather McKenzie
Drug Development
FDA Clears First IND for a Multiplex-Base Edited Investigational Therapy
The FDA has lifted its clinical hold on Beam Therapeutics’ BEAM-201 and cleared the way for an Investigational New Drug Application, the company announced Friday.
December 2, 2022
·
2 min read
·
Tristan Manalac
Global Antibody Drug Conjugates Contract Manufacturing Market 2021 by Company, Regions, Forecast to 2030
The global antibody drug conjugates contract manufacturing market size is expected to be worth around US$ 28.4 billion by 2030, according to a new report by Vision Research Reports.
December 2, 2022
·
3 min read
Neurology Clinical Trials Market Growth, Size, Industry Demands, Region - 2030
The global neurology clinical trials market size is expected to be worth around US$ 12.5 billion by 2030, according to a new report by Vision Research Reports.
December 2, 2022
·
4 min read
Business
Announcing Andrew A. Wilson MD as the Alpha-1 Foundation’s new Scientific Director
The Alpha-1 Foundation announces the appointment of Andrew A. Wilson, MD as its new Scientific Director.
December 2, 2022
·
2 min read
C-reactive Protein Testing Market Size, Share, Growth, Trends, Forecast 2021 to 2030
The global c-reactive protein testing market size is expected to be worth around US$ 10.6 billion by 2030, according to a new report by Vision Research Reports.
December 2, 2022
·
5 min read
1 of 10
Next